WHIPPANY, N.J., May 19, 2016 /PRNewswire/ -- Bayer, an innovative Life Science company, will present the newly introduced scholarship in Visual Multimedia at the 23rd Annual Foreign Press Association (FPA) Scholarship Awards Reception tonight in New York City. The scholarship was created in order to acknowledge the importance of developing young reporters who specialize in visual multimedia, a rapidly advancing field in journalism and media.
"We are proud to continue to partner with and support the FPA. Providing people with opportunities to better themselves and others around them is an integral part of Bayer's mission," said Raymond F. Kerins, Jr., Senior Vice President and Head of Communications, Government Relations and Policy at Bayer Corporation. "The evolution of the media industry has made supporting the integrity and quality of the journalism profession a high priority. Visual multimedia is the next major innovation in journalism. As an innovation company, Bayer is proud to provide this scholarship to aspiring journalists and help them pursue their dreams."
The Foreign Press Association Scholarship Fund (FPASF) was set up 23 years ago in order to aid, develop and cultivate the next generation of international reporters. Since its birth, the FPASF has awarded 79 scholarships to international graduate journalism students. The scholarship awards range from $2,500 to $10,000 and serve as an important financial tool for promising young students.
"The Foreign Press Association in the United States is constantly changing to reflect the realities of today's media industry and the needs of its membership," said David Michaels, President of the Foreign Press Association and its Scholarship Fund. "Multimedia Op-Eds are the way of the future, and Bayer's generous sponsorship of the FPA's new Scholarship Award has allowed the Scholarship Fund to acknowledge this important media advancement."
To find out more about the FPASF and the 2016 awards reception, visit their website: http://www.foreignpressassociation.org/scholarship-fund/.
About Bayer Corporation
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their lives. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2015, the Group employed around 117,000 people and had sales of EUR 46.3 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.3 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to www.bayer.us.
Bayer® and the Bayer Cross® are registered trademarks of Bayer.
This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports, which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.